Asia Pacific Consortium on Osteoporosis (APCO) has launched a comprehensive Bone Health QI Tool Kit today to promote quality improvement … More
Category: Health
Malaysian Genomics Resource Centre Berhad Posts 212% Increase in Revenue for 3Q FY2022
9-month revenue up nearly 12-fold to RM22.03 million Profit supported by higher margin immunotherapy and cell therapies Malaysian Genomics Resource … More
Launch of World-first Expert Bone Health Resource
Putting a brake on fractures in the world’s most populous & fastest ageing region An osteoporotic fracture occurs every three … More
Straumann Malaysia, part of The Straumann Group, a Leading Implantology Company, Intends to Provide 3,000 Dental Implant Packages to the Ministry of Health Malaysia as part of MoU
Straumann Group Sdn. Bhd, the Malaysian subsidiary of Straumann Group, global leader in implantology and aesthetic-dentistry, (Straumann Malaysia) intends to … More
Q&M Dental net profit, excluding other gains or losses, increased by 25% to S$7.2 million on S$46.8 million of revenue for quarter ended 31 March 2022
– Net cash flow from operating activities more than doubled to S$14.7 million for 1Q2022 from S$6.2 million for 1Q2021.– … More
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased … More
Novotech Acquires US CRO NCGS, Expands Global Expertise
Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of its expansion program, and can … More
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced … More
The Executive Talk by ShareInvestor: Thonburi Healthcare Group PCL (SET: THG)
Thonburi Healthcare Group PCL (SET: THG) Chief Executive Officer, Dr. Tanatip Suppradit (M.D.) discusses the business performance during the Covid-19 … More
Legend Capital’s Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis
Legend Capital’s portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the clinical-stage … More
SciTech World News 